abstract |
A composition comprising an isolated monosaccharide for use in the treatment of hemophilia A and / or von Willebrand's disease, wherein the monosaccharide is an accessible sugar residue derived from ABO (H) blood group antigen, wherein the isolated monosaccharide it is one or more of galactose, fucose and Nacetylgalactosamine. |